Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

2
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (1)

Searched Name

Raed Alnutaifi

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

AlRowaie F, Alaryni A, AlGhamdi A, Alajlan R, Alabdullah R, Alnutaifi R, Alnutaifi R, Aldakheelallah A, Alshabanat A, Bin Shulhub A, Moazin O, Qutob R, Alsolami E, Hakami O. Quality of Life among Peritoneal and Hemodialysis Patients: A Cross-Sectional Study. Clin Pract 2023;13:1215-1226. [PMID: 37887085 PMCID: PMC10605737 DOI: 10.3390/clinpract13050109] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Revised: 09/16/2023] [Accepted: 09/25/2023] [Indexed: 10/28/2023] Open

Affiliation(s)

Fadel AlRowaie Nephrology Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia;
Abdullah Alaryni College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Abdullah AlGhamdi College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Renad Alajlan College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Razan Alabdullah College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Raed Alnutaifi College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia;
Raneem Alnutaifi College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Amani Aldakheelallah College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Alanoud Alshabanat College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Abdullah Bin Shulhub College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Othillah Moazin College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Rayan Qutob College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)
Enad Alsolami Department of Internal Medicine, College of Medicine, University of Jeddah, Jeddah P.O. Box 45311, Saudi Arabia;
Osamah Hakami College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; (A.A.); (A.A.); (R.A.); (R.A.); (A.A.); (A.A.); (A.B.S.); (O.M.); (R.Q.); (O.H.)

Collapse

Altamimi I, Almazyed A, Alshammary S, Altamimi A, Alhumimidi A, Alnutaifi R, Malhis M, Altamimi A. Bacterial Pathogens and Antimicrobial Susceptibility Patterns of Urinary Tract Infections in Children during COVID-19 2019-2020: A Large Tertiary Care Center in Saudi Arabia. Children (Basel) 2023;10:971. [PMID: 37371203 DOI: 10.3390/children10060971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 05/24/2023] [Accepted: 05/29/2023] [Indexed: 06/29/2023]

Abstract

BACKGROUND

One of the most prevalent bacterial infections in children is urinary tract infection (UTI), which has become a major concern with increasing resistance of the pathogens to the routinely used antimicrobial agents. The aim of the study is to determine the antimicrobial susceptibility patterns of pediatric UTI-causing pathogens, including ESBL-producing bacteria, in Saudi Arabia.

METHODS

This cross-sectional retrospective study was conducted to ascertain the frequency of isolation and the antimicrobial resistance pattern of uropathogens among children aged 0-15 years. The data from the urine cultures was collected during 2019-2020 at the King Fahad Medical City, a major tertiary hospital in Riyadh, Saudi Arabia. A total of 1022 urine samples from patients diagnosed with urinary tract infections (UTIs) were collected for this study. Microbial species present in the samples were cultured and identified using standard biochemical techniques. To assess the resistance of these strains to antimicrobial drugs, an in vitro method was employed, and the criteria set by the Clinical Laboratory Standard Institute (CLSI) were followed. In addition, a double-disc synergy test was conducted to identify strains of E. coli that produce extended-spectrum beta-lactamase (ESBL).

RESULTS

The predominant pathogens were E. coli (58.6%), followed by Klebsiella sp. (23.9%). E. coli isolates were more sensitive to meropenem and ertapenem in 99.2% of cases, followed by amikacin (99%). Klebsiella sp. were sensitive to amikacin in 97.1% of cases, followed by meropenem and ertapenem (92.2% in both). The highest sensitivities of antimicrobials toward ESBL were for meropenem and ertapenem (100% in both), followed by amikacin (99%).

CONCLUSIONS

Our study recommends using local antibiotic sensitivity data for empirical UTI treatment. Amikacin, ertapenem, and meropenem are effective intravenous options. Cephalosporin, cefuroxime, amoxicillin/clavulanic acid, and nitrofurantoin are suitable oral choices. No significant changes in antimicrobial susceptibility were observed during the COVID-19 pandemic. Further research is needed to assess potential pandemic-related alterations.

Collapse